Eli Lilly announced on Friday that it has applied for U.S. approval of its weight-loss ...
The rapidly increasing demand for a category of weight reduction and diabetes drugs has Eli ...
A panel of independent advisers to the Food and Drug Administration really useful on Monday ...
Every weekday, CNBC Investing Club with Jim Cramer hosts a “Morning Meeting” livestream at 10:20 ...
Eli Lilly announced on Friday that the corporate has invested an extra $5.3 billion in ...
Good day! An extremely popular group of weight reduction and diabetes medications continues to be ...
Amgen's shares rose greater than 12% on Friday after the drugmaker reported positive early data ...
Most doses of Eli LillyHugely popular weight reduction drug Zepbound and its diabetes counterpart Mounjaro ...
Eli Lilly's weight-loss drug Zepbound showed promise for treating sleep apnea — giving investors more ...
Eli Lilly said Wednesday its wildly popular weight-loss drug Zepbound shows the potential to treat ...